OncoMed Pharmaceuticals - 48 Year Dividend Yield History | OMED

Historical dividend payout and yield for OncoMed Pharmaceuticals (OMED) since 1971. The current TTM dividend payout for OncoMed Pharmaceuticals (OMED) as of February 15, 2019 is $0.00. The current dividend yield for OncoMed Pharmaceuticals as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.034B $0.038B
OncoMed Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on the discovering and developing monoclonal antibody therapeutics for cancer stem cells. It utilizes its technologies to identify, isolate and evaluate CSCs, validate multiple potential targets and pathways critical to CSC self-renewal and differentiation and develop antibody and other protein-based therapeutics. The company serves the healthcare industry and cancer therapy patients. OncoMed Pharmaceuticals, Inc. is based in Redwood City, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76